Moreover, in the present study, early stage tumors showed higher COX-2 mRNA expression in comparison to advanced stage tumors in colorectal carcinoma patients, thus, suggesting its use as a potential marker of early progression of the disease, though the expression was even high at all stages. The gene discussed is PTGS2; the disease is colorectal carcinoma.